ORTX Annual Total Liabilities
$120.64 M
+$8.18 M+7.28%
31 December 2022
Summary:
As of February 4, 2025, ORTX annual total liabilities is $120.64 million, with the most recent change of +$8.18 million (+7.28%) on December 31, 2022. During the last 3 years, it has risen by +$20.55 million (+20.54%).ORTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORTX Quarterly Total Liabilities
$122.01 M
-$1.25 M-1.01%
30 September 2023
Summary:
As of February 4, 2025, ORTX quarterly total liabilities is $122.01 million, with the most recent change of -$1.25 million (-1.01%) on September 30, 2023. Over the past year, it has increased by +$11.66 million (+10.57%).ORTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.3% | +10.6% |
| 3 y3 years | +20.5% | +33.7% |
| 5 y5 years | +1007.9% | - |
ORTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -1.0% |
Orchard Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $122.01 M(-1.0%) |
| June 2023 | - | $123.25 M(+6.8%) |
| Mar 2023 | - | $115.36 M(-4.4%) |
| Dec 2022 | $120.64 M(+7.3%) | $120.64 M(+9.3%) |
| Sept 2022 | - | $110.35 M(-2.3%) |
| June 2022 | - | $112.89 M(-2.6%) |
| Mar 2022 | - | $115.86 M(+3.0%) |
| Dec 2021 | $112.46 M(+9.7%) | $112.46 M(-1.7%) |
| Sept 2021 | - | $114.36 M(+13.9%) |
| June 2021 | - | $100.38 M(+7.3%) |
| Mar 2021 | - | $93.53 M(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $102.50 M(+2.4%) | $102.50 M(+12.3%) |
| Sept 2020 | - | $91.25 M(+4.2%) |
| June 2020 | - | $87.56 M(-3.0%) |
| Mar 2020 | - | $90.29 M(-9.8%) |
| Dec 2019 | $100.09 M(+83.0%) | $100.09 M(+33.5%) |
| Sept 2019 | - | $75.00 M(-13.8%) |
| June 2019 | - | $86.96 M(+107.8%) |
| Mar 2019 | - | $41.84 M(-23.5%) |
| Dec 2018 | $54.70 M(+402.4%) | $54.70 M(+9.6%) |
| June 2018 | - | $49.90 M(+358.3%) |
| Dec 2017 | $10.89 M(-47.7%) | $10.89 M |
| Dec 2016 | $20.81 M | - |
FAQ
- What is Orchard Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Orchard Therapeutics?
- What is Orchard Therapeutics annual total liabilities year-on-year change?
- What is Orchard Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Orchard Therapeutics?
- What is Orchard Therapeutics quarterly total liabilities year-on-year change?
What is Orchard Therapeutics annual total liabilities?
The current annual total liabilities of ORTX is $120.64 M
What is the all time high annual total liabilities for Orchard Therapeutics?
Orchard Therapeutics all-time high annual total liabilities is $120.64 M
What is Orchard Therapeutics annual total liabilities year-on-year change?
Over the past year, ORTX annual total liabilities has changed by +$8.18 M (+7.28%)
What is Orchard Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ORTX is $122.01 M
What is the all time high quarterly total liabilities for Orchard Therapeutics?
Orchard Therapeutics all-time high quarterly total liabilities is $123.25 M
What is Orchard Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ORTX quarterly total liabilities has changed by +$11.66 M (+10.57%)